PUBLISHER: Grand View Research | PRODUCT CODE: 1986666
PUBLISHER: Grand View Research | PRODUCT CODE: 1986666
The global eubiotics market size was estimated at USD 6.28 billion in 2025 and is projected to reach USD 12.57 billion by 2033, growing at a CAGR of 9.1% from 2026 to 2033. The demand for the product is anticipated to be driven by favorable regulatory scenario banning the usage of antibiotics and growing meat consumption across the globe.
The market experiences high competition with well-established and long-term operating players enjoying major market share. Companies are heavily investing in R&D activities to develop sustainable technologies for manufacturing cost effective and affordable products. Lack of adequate number of players in several countries specifically in Middle East opens ample of opportunities for new players to enter and gain strong foot hold in the market.
Eubiotics are manufactured and are distributed either through feed mills, pre-mixers, or specific distributors. The companies involved in manufacturing eubiotics either sell their products directly to their consumers or sell them to integrated feed producers. Either way, the eubiotic products reach the livestock producers. Eubiotics, such as organic acids, are manufactured by processes such as fermentation and chemical synthesis. Mostly, the chemical synthesis process is preferred for animal feed applications such as silage and feed additives.
Eubiotics prices are majorly influenced by raw material availability, agro-climatic conditions, and regional jurisdictions etc. The manufacturers compete based on competitive pricing owing to the presence of price- sensitive buyers. The manufacturers are focused on process innovation and low-cost raw material procurement to gain a competitive advantage in the market. Furthermore, the fast growth of end use applications including feed, pharmaceutical, among others, along with increasing production of eubiotics, which is inclined to bridge the gap between supply and demand, is further projected to moderately increase the prices over the forecast period.
Eubiotic products such as prebiotics and probiotics are an important part of the value chain of the nutraceuticals industry. Developing economies, including India and China, are well-positioned in market, owing to technological advancement, low-cost labor, and abundant availability of raw materials due to upscale production. Key players in developing economies are, thus, creating an optimized process and a robust supply chain for cost-effective product manufacturing, thereby offering product at comparatively lower prices.
Global Eubiotics Market Report Segmentation
This report forecasts revenue growth at global, regional, and country levels and provides an analysis on the latest industry trends in each of the sub-segments from 2018 to 2033. For this study, Grand View Research has segmented the global eubiotics market report based on product, form, application, end use, and region: